68 Ga-PSMA for High Risk Prostate Cancer

NCT04614363 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
High Risk

Interventions

DRUG: 68Ga-PSMA

Sponsor

The Methodist Hospital Research Institute